On the one hand, SNHG5 was found to be expressed at low levels in gastric cancer and to suppress the ability of gastric cancer cells to migrate and proliferate both in vitro and in vivo by inhibiting the translocation of MTA2 (metastasis-associated gene2) into the nucleus through interacting with MTA [36]. The gene discussed is MTA2; the disease is gastric cancer.